As of 2025-11-18, the EV/EBITDA ratio of Sprint Bioscience AB (SPRINT.ST) is -2.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SPRINT.ST's latest enterprise value is 47.10 mil SEK. SPRINT.ST's TTM EBITDA according to its financial statements is -21.22 mil SEK. Dividing these 2 quantities gives us the above SPRINT.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.7x - 13.7x | 9.9x |
| Forward P/E multiples | 14.8x - 17.2x | 15.0x |
| Fair Price | (2.75) - (2.51) | (2.27) |
| Upside | -504.5% - -469.6% | -433.8% |
| Date | EV/EBITDA |
| 2025-11-14 | -2.22 |
| 2025-11-13 | -2.04 |
| 2025-11-12 | -2.06 |
| 2025-11-11 | -2.07 |
| 2025-11-10 | -2.17 |
| 2025-11-07 | -2.35 |
| 2025-11-06 | -2.45 |
| 2025-11-05 | -2.43 |
| 2025-11-04 | -2.34 |
| 2025-11-03 | -2.43 |
| 2025-10-31 | -2.31 |
| 2025-10-30 | -2.28 |
| 2025-10-29 | -2.45 |
| 2025-10-28 | -2.37 |
| 2025-10-27 | -2.37 |
| 2025-10-24 | -2.32 |
| 2025-10-23 | -2.32 |
| 2025-10-22 | -2.32 |
| 2025-10-21 | -2.30 |
| 2025-10-20 | -2.32 |
| 2025-10-17 | -2.49 |
| 2025-10-16 | -2.45 |
| 2025-10-15 | -2.46 |
| 2025-10-14 | -2.58 |
| 2025-10-13 | -2.44 |
| 2025-10-10 | -2.15 |
| 2025-10-09 | -2.02 |
| 2025-10-08 | -2.17 |
| 2025-10-07 | -2.32 |
| 2025-10-06 | -2.31 |
| 2025-10-03 | -1.85 |
| 2025-10-02 | -1.70 |
| 2025-10-01 | -1.77 |
| 2025-09-30 | -1.70 |
| 2025-09-29 | -1.67 |
| 2025-09-26 | -1.62 |
| 2025-09-25 | -1.62 |
| 2025-09-24 | -1.73 |
| 2025-09-23 | -1.76 |
| 2025-09-22 | -1.62 |
| 2025-09-19 | -1.63 |
| 2025-09-18 | -1.67 |
| 2025-09-17 | -1.76 |
| 2025-09-16 | -1.64 |
| 2025-09-15 | -1.76 |
| 2025-09-12 | -1.88 |
| 2025-09-11 | -1.83 |
| 2025-09-10 | -1.82 |
| 2025-09-09 | -1.73 |
| 2025-09-08 | -1.87 |